Kura partners with Kyowa Kirin to advance AML treatment
The partnership involves commercialising and developing the therapy for treating acute myeloid leukaemia and other hematologic malignancies. Credit: Rachaphak/Shutterstock. Kura Oncology has partnered Kyowa Kirin